| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 2, Issue 3 137-143, Copyright © 1991 by American Association of Cancer Research
ARTICLES |
D Grinberg, J Thurlow, R Watson, R Smith, G Peters and C Dickson
Imperial Cancer Research Fund Laboratories, Lincoln's Inn Fields, London.
The int-2 gene, which encodes a member of the fibroblast growth factor family, is expressed at specific sites and times during mouse development. In certain embryonal carcinoma cell lines, multiple int-2 transcripts accumulate when the cells are induced to differentiate with retinoic acid and dibutyryl cyclic AMP. Nuclear run-on analyses indicate that the apparent induction of int-2 expression results from an increase in the rate of transcription initiation. Six distinct types of RNA have been delineated, originating from three promoters and terminating at either of two polyadenylation sites. Since each transcript appears to encode the same protein, this complexity may reflect the need for lineage-specific or differentiation-dependent control of expression. By comparing the kinetics of induction and turnover of the different RNA species, we show that the choice of promoter or length of the 3'-untranslated region has no significant effect on the half-lives of the various mRNAs. To further evaluate control at the transcriptional level, we have shown that a 1.7-kilobase fragment of int-2 genomic DNA, when fused to the chloramphenicol acetyltransferase gene, can act as a regulated promoter(s) in differentiated versus undifferentiated embryonal carcinoma cells. This segment of DNA encompasses the three promoter regions previously delineated by RNase mapping plus about 900 base pairs of additional upstream sequences.
This article has been cited by other articles:
![]() |
A. Murakami, H. Shen, S. Ishida, and C. Dickson SOX7 and GATA-4 Are Competitive Activators of Fgf-3 Transcription J. Biol. Chem., July 2, 2004; 279(27): 28564 - 28573. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Murakami, S. Ishida, and C. Dickson GATA-4 interacts distinctively with negative and positive regulatory elements in the Fgf-3 promoter Nucleic Acids Res., February 15, 2002; 30(4): 1056 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Murakami, S. Ishida, J. Thurlow, J.-M. Revest, and C. Dickson SOX6 binds CtBP2 to repress transcription from the Fgf-3 promoter Nucleic Acids Res., August 15, 2001; 29(16): 3347 - 3355. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Antoine, M. Daum, R. Köhl, V. Blecken, M. J. Close, G. Peters, and P. Kiefer NH2-Terminal Cleavage of Xenopus Fibroblast Growth Factor 3 Is Necessary for Optimal Biological Activity and Receptor Binding Cell Growth Differ., November 1, 2000; 11(11): 593 - 605. [Abstract] [Full Text] |
||||
![]() |
A. Murakami, J. Thurlow, and C. Dickson Retinoic Acid-regulated Expression of Fibroblast Growth Factor 3 Requires the Interaction between a Novel Transcription Factor and GATA-4 J. Biol. Chem., June 11, 1999; 274(24): 17242 - 17248. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gemel, C. Jacobsen, and C. A. MacArthur Fibroblast Growth Factor-8 Expression Is Regulated by Intronic Engrailed and Pbx1-binding Sites J. Biol. Chem., February 26, 1999; 274(9): 6020 - 6026. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Grimm and S. K. Nordeen Mouse Mammary Tumor Virus Sequences Responsible for Activating Cellular Oncogenes J. Virol., December 1, 1998; 72(12): 9428 - 9435. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Kutty, G. Kutty, W. Samuel, T. Duncan, C. C. Bridges, A. El-Sherbeeny, C. N. Nagineni, S. B. Smith, and B. Wiggert Molecular Characterization and Developmental Expression of NORPEG, a Novel Gene Induced by Retinoic Acid J. Biol. Chem., January 19, 2001; 276(4): 2831 - 2840. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Galdemard, H. Yamagata, O. Brison, and C. Lavialle Regulation of FGF-3 Gene Expression in Tumorigenic and Non-tumorigenic Clones of a Human Colon Carcinoma Cell Line J. Biol. Chem., June 2, 2000; 275(23): 17364 - 17373. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |